Physician

Ahmad Subhi Jabbar, M.D.

According to 2025 Medicare claims, Ahmad Jabbar, M.D. (NPI: 1831538289) practices dermatology in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Cook, IL. This provider's primary affiliated billing organization is ENDEAVOR HEALTH MEDICAL GROUP (NPI: 1497701882; TIN: 363738206) and primary practice location at 60004-2315.

Jabbar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 617 traditional Medicare patients, billed 3,320 HCPCS/CPT codes, and received $218,161 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 946 prescription claims across 320 beneficiaries totaling $285,682 in drug costs, led by Otezla (Apremilast). Open Payments data shows 1 records totaling $36. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $40,837 and ending at $218,161. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $37,530 to $285,682. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$169K$338K2017 Medicare payment: $40,837 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $133,730 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $337,956 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $157,517 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $135,909 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $131,023 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $133,067 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $218,161 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017229739$40,837
20185082,309$133,730
20198354,813$337,956
20205422,330$157,517
20214901,803$135,909
20224971,939$131,023
20235311,956$133,067
20246173,320$218,161

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$143K$286K2015 Drug cost: $37,530 (USD; Tot_Drug_Cst)2016 Drug cost: $26,841 (USD; Tot_Drug_Cst)2017 Drug cost: $35,933 (USD; Tot_Drug_Cst)2018 Drug cost: $45,999 (USD; Tot_Drug_Cst)2019 Drug cost: $237,420 (USD; Tot_Drug_Cst)2020 Drug cost: $247,366 (USD; Tot_Drug_Cst)2021 Drug cost: $151,638 (USD; Tot_Drug_Cst)2022 Drug cost: $194,241 (USD; Tot_Drug_Cst)2023 Drug cost: $205,475 (USD; Tot_Drug_Cst)2024 Drug cost: $285,682 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201531175$37,530
201633213$26,841
201794342$35,933
2018206501$45,999
2019355940$237,420
2020263607$247,366
2021283772$151,638
2022272831$194,241
2023276799$205,475
2024320946$285,682

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more465597$142
17004Destruction of precancer skin growth, 15 or more growths106142$139
17110Destruction of skin growth, 1-14 growths385482$94
17000Destruction of precancer skin growth, 1 growth388457$35
17003Destruction of precancer skin growth, 2-14 growths2471,036$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
OtezlaApremilast28900$120,166
Dupixent PenDupilumab11308$37,504
PimecrolimusPimecrolimus15640$5,406
Clobetasol PropionateClobetasol Propionate832,227$3,650
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc34851$2,407

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$36Lilly USA, LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ahmad Subhi Jabbar, M.D.?

Tedicare shows public-source Medicare data for Ahmad Subhi Jabbar, M.D. (NPI 1831538289), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ahmad Subhi Jabbar, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ahmad Subhi Jabbar, M.D.?

Ahmad Subhi Jabbar, M.D. is linked to ENDEAVOR HEALTH MEDICAL GROUP (billing NPI 1497701882) in the available physician profile data.

Does Ahmad Subhi Jabbar, M.D. have Open Payments data?

Ahmad Subhi Jabbar, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.